On October 28, 2024, AIIMS Delhi announced the start of the GRASSROOT clinical trial in New Delhi. This trial will test the safety and effectiveness of a new stent retriever designed for treating stroke clots. AIIMS explained that this device is specifically made to address the needs of stroke patients in India.
Dr. Sailesh Gaikwad, Head of Neurosciences at AIIMS, stated that the trial aims to improve stroke recovery and set new standards for stroke care. He also mentioned that the treatment would be affordable to make it accessible to more patients in India and globally.
